- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Hospital General Universitario de Alicante](/img/noimage_org.png)
Hospital General Universitario de Alicante
Alicante, EspañaHospital General Universitario de Alicante -ko ikertzaileekin lankidetzan egindako argitalpenak (23)
2024
-
Gastric metaplasia as a precursor of nonconventional dysplasia in inflammatory bowel disease
Human Pathology, Vol. 143, pp. 50-61
2023
-
Alterations in p53, Microsatellite Stability and Lack of MUC5AC Expression as Molecular Features of Colorectal Carcinoma Associated with Inflammatory Bowel Disease
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort
Antibiotics, Vol. 12, Núm. 1
-
Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial
The Journal of antimicrobial chemotherapy, Vol. 78, Núm. 7, pp. 1658-1666
-
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402
Journal of the National Cancer Institute, Vol. 115, Núm. 12, pp. 1497-1505
2022
-
Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis
Life, Vol. 12, Núm. 12
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Effectiveness of Fosfomycin for the Treatment of Multidrug-Resistant Escherichia coli Bacteremic Urinary Tract Infections: A Randomized Clinical Trial
JAMA Network Open, Vol. 5, Núm. 1
-
Pseudomonas aeruginosa Community-Onset Bloodstream Infections: Characterization, Diagnostic Predictors, and Predictive Score Development—Results from the PRO-BAC Cohort
Antibiotics, Vol. 11, Núm. 6
-
Recommendations of the Spanish Society of Thoracic Surgery for the management of malignant pleural effusion
Cirugia Espanola, Vol. 100, Núm. 11, pp. 673-683
2021
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
-
High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions
Patient, Vol. 14, Núm. 2, pp. 241-248
-
Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC Study)
International Journal of Antimicrobial Agents, Vol. 58, Núm. 1
2020
-
Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma
Journal of the European Academy of Dermatology and Venereology, Vol. 34, Núm. 4, pp. 762-768
-
Psychometric Properties of the SymptoMScreen Questionnaire in a Mild Disability Population of Patients with Relapsing–Remitting Multiple Sclerosis: Quantifying the Patient’s Perspective
Neurology and Therapy, Vol. 9, Núm. 1, pp. 173-179
2018
-
Biomarkers of carcinogenesis and tumour growth in patients with cutaneous melanoma and obstructive sleep apnoea
European Respiratory Journal, Vol. 51, Núm. 3
-
First-line treatment in lymphomatoid papulosis: a retrospective multicentre study
Clinical and Experimental Dermatology, Vol. 43, Núm. 2, pp. 137-143
-
Sleep-Disordered Breathing Is Independently Associated With Increased Aggressiveness of Cutaneous Melanoma: A Multicenter Observational Study in 443 Patients
Chest, Vol. 154, Núm. 6, pp. 1348-1358
2015
2014
-
Guidelines for biomarker testing in gastroenteropancreatic neuroendocrine neoplasms: A national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 16, Núm. 3, pp. 243-256